Liu Yi-Hsiang, Pei Ren-Jeng, Cheng Chiung-Chi, Ho Heng-Chien, Ho Chin-Chin, Yeh Kun-Tu, Lee Karen Ying, Lai Yih-Shyong
Research Center, Chung Tai Institute of Health Sciences and Technology, Takun, Taichung, Taiwan.
Res Commun Mol Pathol Pharmacol. 2002;112(1-4):27-38.
The stability of cytokeratin (CK) protein during tumor transformation in human hepatocellular carcinoma (HCC) was studied with molecular approach previously. The results demonstrated that the CK was modulated in human HCC. Besides this, three low molecular weight CK molecules (named HCC CK) were found. It indicated that these HCC CKs are undergone modulation from human hepatocyte CK18. However, there were many differences between the CK18 and HCC CK. First, the antigenecity of HCC CK had been changed since they could not be recognized by CAM5.2 antibody on Western blot. Second, the sequences of N-terminal residues of HCC CK were matched with those of the N-terminal residues of human histone. In this study, we confirmed that the HCC CK was actually to be histones because they reacted to anti-histone antibody on Western blot. Furthermore, we found that the histones of human HCC had been changed during the process of tumor transformation since they could be co-immunoprecipitated with CK18 and could be detected by Western blot while this phenomenon did not happen in the normal liver tissue. We also found that not all histones change in human HCC. Only H3 was detected on Western blot while H1, H2A, H2B, and H4 were not detected in human HCCs.
先前已采用分子方法研究了细胞角蛋白(CK)蛋白在人肝细胞癌(HCC)肿瘤转化过程中的稳定性。结果表明,CK在人HCC中受到调控。除此之外,还发现了三种低分子量CK分子(命名为HCC CK)。这表明这些HCC CK是由人肝细胞CK18调控而来。然而,CK18和HCC CK之间存在许多差异。首先,HCC CK的抗原性发生了变化,因为在蛋白质印迹上它们不能被CAM5.2抗体识别。其次,HCC CK的N端残基序列与人类组蛋白的N端残基序列相匹配。在本研究中,我们证实HCC CK实际上就是组蛋白,因为它们在蛋白质印迹上能与抗组蛋白抗体发生反应。此外,我们发现人HCC的组蛋白在肿瘤转化过程中发生了变化,因为它们能与CK18进行共免疫沉淀,并且能通过蛋白质印迹检测到,而在正常肝组织中未出现这种现象。我们还发现并非人HCC中的所有组蛋白都会发生变化。在人HCC中,蛋白质印迹仅检测到H3,而未检测到H1、H2A、H2B和H4。